Point-of-Care Capillary Whole Blood Hematocrit and Hemoglobin Compared
By LabMedica International staff writers Posted on 14 Jun 2015 |
The clinical suitability of point-of-care devices for conductivity based point-of-care hematocrit with calculated hemoglobin necessitates that they be accurate and that the results are interchangeable with central laboratory methods.
The appropriateness of conductivity based assays in certain patient populations, such as patients on cardiopulmonary bypass and those receiving high volumes of intravenous fluids or autologous blood transfusions, has been questioned.
Clinical laboratory scientists at Massachusetts General Hospital (Boston, MA, USA) performed hematocrit and hemoglobin analysis on 225 clinical samples obtained from intensive care units and the cardiac surgery operating room. All samples were from adult patients over 18 years of age. The samples were first tested for clinical care and then immediately handed off to technologists for the study testing.
The total hemoglobin level was first measured by co-oximetry on the Siemens RAPIDLab 1265 analyzer (Siemens Medical Solutions USA, Inc.; Malvern, PA, USA). Hematocrit and hemoglobin values were obtained on the Abbott i-STAT instrument using one lot of i-STAT E3+ cartridges (Abbott Point of Care; Princeton, NJ, USA). Hemoglobin values from the i-STAT are performed by the calculation of directly measured hematocrit in percent × 0.34. A manual spun hematocrit was performed on each sample as the standard hematocrit reference method. The hematocrit and hemoglobin were also determined on the automated hematology analyzer XE5000 (Sysmex Corporation; Kobe, Japan) by impedance based cumulative pulse height detection and by photometric determination, respectively.
The i-STAT hematocrit and hemoglobin showed close agreement to comparison methods with minimal bias. Median test results were not clinically or statistically different between those measured on the i-STAT and those measured using the manual spun hematocrit reference method or the Sysmex photometric hemoglobin method. The results on the i-STAT were statistically significantly different from those obtained on the Sysmex for hematocrit and the Siemens RAPIDLab co-oximeter for hemoglobin.
The authors concluded that the i-STAT hematocrit and hemoglobin performs well when compared to the hematocrit reference method and other common methods for both hematocrit and hemoglobin. Some differences between non-reference methods may be observed, but these were not considered clinically significant. The study was published in the June 2015 issue of the journal Clinica Chimica Acta.
Related Links:
Massachusetts General Hospital
Siemens Medical Solutions USA
Abbott Point of Care
The appropriateness of conductivity based assays in certain patient populations, such as patients on cardiopulmonary bypass and those receiving high volumes of intravenous fluids or autologous blood transfusions, has been questioned.
Clinical laboratory scientists at Massachusetts General Hospital (Boston, MA, USA) performed hematocrit and hemoglobin analysis on 225 clinical samples obtained from intensive care units and the cardiac surgery operating room. All samples were from adult patients over 18 years of age. The samples were first tested for clinical care and then immediately handed off to technologists for the study testing.
The total hemoglobin level was first measured by co-oximetry on the Siemens RAPIDLab 1265 analyzer (Siemens Medical Solutions USA, Inc.; Malvern, PA, USA). Hematocrit and hemoglobin values were obtained on the Abbott i-STAT instrument using one lot of i-STAT E3+ cartridges (Abbott Point of Care; Princeton, NJ, USA). Hemoglobin values from the i-STAT are performed by the calculation of directly measured hematocrit in percent × 0.34. A manual spun hematocrit was performed on each sample as the standard hematocrit reference method. The hematocrit and hemoglobin were also determined on the automated hematology analyzer XE5000 (Sysmex Corporation; Kobe, Japan) by impedance based cumulative pulse height detection and by photometric determination, respectively.
The i-STAT hematocrit and hemoglobin showed close agreement to comparison methods with minimal bias. Median test results were not clinically or statistically different between those measured on the i-STAT and those measured using the manual spun hematocrit reference method or the Sysmex photometric hemoglobin method. The results on the i-STAT were statistically significantly different from those obtained on the Sysmex for hematocrit and the Siemens RAPIDLab co-oximeter for hemoglobin.
The authors concluded that the i-STAT hematocrit and hemoglobin performs well when compared to the hematocrit reference method and other common methods for both hematocrit and hemoglobin. Some differences between non-reference methods may be observed, but these were not considered clinically significant. The study was published in the June 2015 issue of the journal Clinica Chimica Acta.
Related Links:
Massachusetts General Hospital
Siemens Medical Solutions USA
Abbott Point of Care
Read the full article by registering today, it's FREE!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Hematology News
- Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
- First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
- POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
- First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
- Handheld White Blood Cell Tracker to Enable Rapid Testing For Infections
- Smart Palm-size Optofluidic Hematology Analyzer Enables POCT of Patients’ Blood Cells
- Automated Hematology Platform Offers High Throughput Analytical Performance
- New Tool Analyzes Blood Platelets Faster, Easily and Accurately
- First Rapid-Result Hematology Analyzer Reports Measures of Infection and Severity at POC
- Bleeding Risk Diagnostic Test to Reduce Preventable Complications in Hospitals
- True POC Hematology Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput
- Point of Care CBC Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput
- Blood Test Could Predict Outcomes in Emergency Department and Hospital Admissions
- Novel Technology Diagnoses Immunothrombosis Using Breath Gas Analysis
- Advanced Hematology System Allows Labs to Process Up To 119 Complete Blood Count Results per Hour
- Unique AI-Based Approach Automates Clinical Analysis of Blood Data